# Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers

> **NCT05588531** · PHASE1 · COMPLETED · sponsor: **Nanjing Yoko Biomedical Co., Ltd.** · enrollment: 66 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Group 1:YK-1169
- **DRUG:** Group 2:YK-1169/Placebo Injection
- **DRUG:** Group 3:YK-1169/Placebo
- **DRUG:** Group 4:YK-1169/Placebo
- **DRUG:** Group 5:YK-1169/Placebo Injection
- **DRUG:** Group 6:YK-1169/Cefepime hydrochloride for injection/Avibactam for injection

## Key facts

- **NCT ID:** NCT05588531
- **Lead sponsor:** Nanjing Yoko Biomedical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-20
- **Primary completion:** 2022-04-02
- **Final completion:** 2022-04-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05588531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05588531, "Study on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05588531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*